The Ras oncogene transforms cultured murine ®broblasts into malignant, focus-forming cells, whose lack of contact inhibition is evidenced by high saturation densities. In order to investigate the reversibility of Ras transformation, as well as the kinetics of Ras-induced changes, cell lines that conditionally express oncogenic Ras were constructed. Both focus formation and increased saturation density were inducible and fully reversible. In exponentially growing cells, oncogenic Rasexpression had no eect on proliferation rates, Erk phosphorylation, or the level of cyclin D1, and Rasinduction did not confer serum-independent growth. As expected, growth to high density in uninduced cells led to quiescence with a low level of cyclin D1 and no active Erk; in this setting, Ras induction prevented full downregulation of cyclin D1 and inactivation of Erk. Our results show that Ras expression to a level sucient for transformation leads to relatively subtle eects on known downstream targets, and that the focus formation and increased saturation density growth induced by Ras is not a result of growth factor independence.
Introduction
Transformation of rodent ®broblasts is a de®ning in vitro biological activity of the ras oncogene. Plated among immortal, non-tumorigenic parental cells, the ras transformed cells exhibit loss of contact inhibition and grow as foci of transformed cells (Simons et al., 1967) . Cells cloned from these foci grow in soft agar as anchorage-independent colonies (Zavada and Macpherson, 1970) and are tumorigenic in suitable hosts (Harvey and East, 1971) . The oncogenic ras alleles arise by point mutation from endogenous ras genes (reviewed in Lowy and Willumsen, 1993) and lead to expression of constitutively active Ras proteins, which activate the Ras-Raf-MEK-MAPK pathway (Leevers and Marshall, 1992) and the PI-3 kinase pathway (Rodriguez-Viciana et al., 1994) . Endogenous Ras activity is necessary for signal transduction from growth factor receptors to initiation of DNA synthesis in both mitogen-stimulated, serum starved cells as well as in cycling cells (Mulcahy et al., 1985) . The Rb protein, whose phosphorylation by G1 cyclin dependent kinases leads to E2F-transcription factor mediated induction of S phase activities, regulates cell cycle progression from G1 to S phase (Weinberg, 1995) . In Rb negative cells, initiation of DNA replication is to a large extent independent of Ras activity (Leone et al., 1997; Mittnacht et al., 1997; Peeper et al., 1997) , suggesting that an important Ras function might be to promote Rb inactivation. The Ras stimulated pathways induce (Filmus et al., 1994; Albanese et al., 1995; Lavoie et al., 1996) and stabilize (Diehl et al., 1998; Gille and Downward, 1999 ) the cdk4 activator cyclin D1, implying that in Ras transformed cells, cdk4 kinase activity and thus Rb inactivation, would not be limiting for cell cycle progression. Oncogenic transformation in immortalized cells occurs when members of the Ras-Raf-MEK pathway mutate to constitutively active forms. Based on these and many other observations, transformation is thought to arise when the signal now emanating from the active oncoprotein mimics the activity of serum growth factors. In support of this serum-mimicking phenotype of the ras-oncogene, activated ras, in serum starved cells, leads to induction of serum responsive genes and to activation of cell cycle regulators crucial to cycling. The cyclin D1, fos and other immediate early/delayed early genes are Ras-inducible (SchoÈ nthal et al., 1988; Albanese et al., 1995) , and cdk4-cyclin D1 kinase (Villalonga et al., 2000) and the E2F transcription factors (Fan and Bertino, 1997; Gjoerup et al., 1998) are active in Rastransformed, but not parental, serum starved cells. This ®nding is in accord with many reports (Kaplan et al., 1982; Durkin and Whit®eld, 1986; Zhan and Goldfarb, 1986; Pironin et al., 1992; Winston et al., 1996; Villalonga et al., 2000) , the results of which argue that activated Ras can induce DNA synthesis, but that cell division in the absence of serum may require Rasinduced autocrine growth-factor production.
The molecular biology of the Ras oncogene has principally been investigated by comparisons between transformed cells and the parental cell line, where unidenti®ed genetic changes contributing to the malig-nant phenotype might take place during the selection of the transformed cells. To gain insight into the direct Ras-mediated eects on physiology as well as molecular biology, we have selected cells that form foci conditionally and reversibly. We ®nd that the transforming activity of oncogenic Ras is sucient to relieve cells from contact inhibition, but does not confer a proliferative advantage to cells in low serum. Cyclin D1 levels were equivalent in transformed and nontransformed cells during exponential growth. As for other cell types (Won et al., 1992; Winston et al., 1996) in the growth phase where control cells become contact-inhibited, cyclin D1 levels decline drastically, whereas only a moderate reduction is seen in the ras cells. We conclude that rather than elevated expression in cycling cells, it is sustained cyclin D1 expression at high cell density which correlates with Ras-induced focus forming activity. Importantly, our data show that despite quite moderate eects on known downstream targets Ras is sucient to induce a fully transformed phenotype.
Results

Isolation of cells with conditional focus formation
Two systems for inducible gene expression in mammalian cells were used to generate lines which expressed the oncogenic v-H-ras gene, both of which employ small-molecule regulators that are unlikely to in¯uence the physiology of tissue culture cells. The IPTGinducible lacO-based system (Brown et al., 1987; Hu and Davidson, 1987; Jacobsen and Willumsen, 1995) , was used to select the lines 60V1.3 and 60V1.9, and the tetracycline (tet) repressible (tet O) tetO-based system (Gossen and Bujard, 1992) to select lines Mib 123, Mib 124 and Mib 125. For each system, control cell lines transfected with v-H-ras that were not inducible were also isolated. The v-H-ras encodes the Harvey Ras protein carrying two independently activating mutations: one at amino acid 12, glycine to arginine, and one at amino acid 59, alanine to threonine. The latter mutation results in the occasional generation of a phosphorylated Ras protein which migrates more slowly in an SDS gel, is biologically inactive, and is more stable than the non-phosphorylated form (Shih et al., 1982; Ulsh and Shih, 1984; Chung et al., 1992) . This form thus serves as a sensitive marker for expression of the exogenous gene. The cell clones were screened for the ability to form foci under induced conditions (in the presence of IPTG for the lacO system, in the absence of tetracycline for the tetO system), in the presence of untransfected, parental NIH3T3 cells. All ®ve cell lines formed foci with eciencies similar to the constitutively transformed controls under induced conditions and fewer or none under uninduced conditions (Figure 1 ; Tables 1 and 2 ). The lacO system appeared to have a higher degree of leakiness, although it was possible to propagate cell lines without overgrowth of constitutively transformed variants, indicating that the phenotype seemed to express itself only under the focus-formation conditions. The tetO controlled cells were more tightly controlled since no foci developed when up to 3000 cells were plated under conditions where the same number of constitutively transformed cells would form 1000 foci. In all ®ve cell lines, inducing conditions were associated with expression of Ras protein: the phosphorylated v-H-Ras protein, diagnostic for expression of the exogenous ras, was observed in constitutive and induced cell lines, but absent in vector controls (Figure 1c,d) . Cells from foci developed from Mib 123 and Mib 125 in the absence of tet were picked and expanded in the presence of tet where they exhibited non-transformed morphology at all densities. Two focus-derived lines (Mib 123 F1 and 2) were tested for tet-dependent focus-formation in the co-cultivation assay. Neither formed foci in the presence of tet but retained the transforming ability under Ras-inducing conditions (Table 2 and data not shown). We conclude that the focus-forming phenotype accompanying the induction of oncogenic Ras was fully reversible.
Ras-induced cells have unchanged doubling time but reversibly increased saturation densities and morphological changes
One phenotype of oncogenically transformed, focusforming cells is an increase in saturation density. This is the cell density at which cell division ceases although sucient serum factors are still present and able to sustain the growth of sparse cultures. To test if this phenotype requires long term expression of Ras oncogene, we compared the growth properties of constitutively Ras-transformed cell lines with that of short term expression by measuring growth rate and saturation densities under conditions where the Ras oncogene had been induced one to four generation times. In none of the inducible cell lines could we detect any changes in doubling time during exponential growth (below ca. 6610 4 cells/cm 2 ) with Ras induction (Figure 2a ,b and data not shown); this absence of an eect on growth rates was also seen with numerous pools or clones of constitutively Ras-transformed cells. However, a signi®cant change in saturation density was clear, even if v-H-Ras was induced just as the cells had reached this density. The high density-growth was reversible since cells that had been induced three to four cell doubling times earlier exhibited a lower saturation density upon removal of the Ras-inducing stimulus (Figure 2c,d) .
Few or no morphological changes were readily detectable in exponentially growing, Ras-induced cells (Figure 2e ). However, at higher cell densities, the v-HRas-expressing cells transformed morphologically and grew in a manner typical for the constitutively transformed cell lines (Figure 2f ). The multi-layered morphology characteristic of Ras-transformed cells became apparent at the cell densities where the nontransformed cells were forming a monolayer of contact inhibited cells. This shows that the transformed 
Ras-induced cells remain dependent on serum growth factors
To test for the ability of oncogenic Ras to replace serum as a growth stimulant, inducible cells, plated in the presence or absence of tetracycline, were serum starved at a cell density (2610 4 cells/cm 2 ) below the density at which NIH3T3 cells are arrested by contact inhibition. This was done by replacing the medium with medium containing 0.5% serum in addition to the supplements selenite, transferrin and BSA-linoleic acid. For the ®rst 24 h after onset of starvation cell numbers increased with about half the rate of the 10% serum controls for both Ras-induced and uninduced cells (Figure 3a) , re¯ecting the mitoses of cells in the cell cycle phase not sensitive to serum withdrawal (Pardee et al., 1978; Hitomi and Stacey, 1999) . The serum starved cells seemed to increase their area and the nontransformed cells formed a continuous layer at lower cell densities than do cells in 10% serum. Two days after the beginning of starvation, Ras-induced cells were repressed by the addition of tetracycline, and repressed cells induced by its removal. Some slight cell accumulation was seen in the Ras-induced cultures: the culture where the cells had been induced before starvation accumulated cells with an apparent doubling time of 500 h. The culture induced during starvation barely accumulated cells, and at a rate way below the 22 h doubling time in 10% serum. The cultures serumstarved in the absence of oncogenic Ras lost cells, both the uninduced cultures and the cultures that were recently repressed under low serum conditions ( Figure  3a) . Thus, rather than supplying the cells with a full mitotic stimulus, the expression of the oncogenic Ras protein seems in the main to protect against the loss of cells resulting from serum starvation, an eect also seen in constitutively transformed cell lines. However, the cells did adopt the morphology characteristic of their Ras-status: the cells maintained in the absence of tetracycline showed the transformed, refractile cells (Figure 3b ), indicating that the Ras-associated morphological changes to a large extent are independent of high concentrations of serum factors.
Effect of induced oncogenic Ras protein expression on MAPK and cyclin D1
The molecular manifestation of expression of activated Ras on signal transduction and gene expression was analysed by evaluation of the levels of phosphorylated Erk, a substrate of Ras-activated Raf, and cyclin D1, which is positively regulated at multiple levels by Ras. During the ®rst 40 h of growth the cyclin D1 level increased slightly as the cells adapted to exponential growth and active Ras accumulated. However, 40 h after replating and induction of Ras, no dierence in cyclin D1 level was observed between the Ras induced cultures and controls (Figure 4c, 40 h ). Thus the gradual increase in cyclin D1 re¯ects physiological changes perhaps re¯ecting resumption of activity after replating, rather than the Ras status. We conclude that under optimal and exponential growth conditions the accumulation of oncogenic Ras does not signi®cantly alter the level of cyclin D1, whereas we see a small eect on the activity of the MAPK pathway evaluated by the presence of pErk (Figure 4c and data not shown). At higher cell densities, where non-transformed NIH3T3 cells experience contact inhibition, the non-induced cells showed no detectable pErk and very low levels of cyclin D1 protein when reaching quiescence. In contrast, the Ras induced cells retained a higher level of cyclin D1 and pErk, although they too experience a delayed growth arrest (Figure 4b,d) . These results indicate that the eect of activated Ras on its downstream eectors is limited during exponential growth conditions, but does manifest itself under limiting growth conditions, as cells experience cell ± cell interaction and growth inhibition. Thus, large eects on the downstream Ras targets seems not to be required for activated Ras to elicit a full transformed phenotype. conditional transformation. This system has been developed with NIH3T3 cells, an established rodent line that has been used extensively to study transformation by ras and other oncogenes. The transformed morphology of C7 3T3 cells expressing an estradiol inducible Raf fusion protein was seen to revert to¯at morphology in the absence of estradiol (Samuels et al., 1993) ; when ras was induced in our lines, the cells became transformed, while cessation of v-H-ras synthesis led to complete reversion of focus-formation ability and re-imposed contact inhibition. This behavior was also seen in cells picked from induced foci, supporting the notion that in immortalized ®broblastic cells only a single genetic event is required for acquisition of the focus-forming phenotype. The NIH3T3 cell line harbors a deletion of the INK locus, which encodes both p16
Ink4A and p19 ARF (Quelle et al., 1995) . This deletion leads to immortalization and allows for direct focus-formation by the ras oncogene (Serrano et al., 1996; Kamijo et al., 1997) , and the line is susceptible to transformation by constitutively activated members of the Ras ± Raf pathway (neu, sos, raf, MEK) as well as other signaling molecules (mos, src). Our biologic observations are contrary to conventional perceptions of Ras transformation in this system: we ®nd that proliferation of the ras transformed cells remains dependent upon serum, and transforming levels of Ras protein do not alter the growth properties of the cells until they become con¯uent. Cell lines isolated from ras induced melanomas exhibited similar characteristics (Chin et al., 1999) . In addition to the conditionally transformed Ras-cell lines presented here, we have analysed the growth rate of numerous independent ras-transformed NIH3T3 cell clones in several NIH3T3 sublines and never seen altered doubling times at low cell densities of the transformed cells. Similarly, in mouse embryo ®broblast lines which are de®cient for either Arf or p16
Ink4A
, we have also found that in exponentially growing cultures, Ras transformed cells exhibit the same doubling times as parental cells (A Groth, unpublished). Overexpression of cyclin D1 and of a mutant of initiation factor EIf2a have both been reported to decrease the cell cycle time of NIH3T3 cells (Quelle et al., 1993; Donze et al., 1995) . In our inducible system, we saw no signi®cant changes in the cyclin D1 level attributable to the expression of oncogenic Ras during exponential growth, in agreement with our data that ras-induced changes do not result in a growth advantage at low cell densities. The EIf2a mutant induces foci (Donze et al., 1995) , whereas cyclin D1 does not (Hinds et al., 1994 , Liu et al., 1995 . These characteristics argue that there is no obligatory correlation between increased growth rate and focus formation, and indeed, no growth rate change is seen in NIH3T3 cells transformed with other focus-forming genes (BM Willumsen, unpublished) . These biological results imply that in the NIH3T3 system ras can induce transformation without major perturbation of normal cell cycle regulatory control and that Ras activity is not limiting in sub-con¯uent cells.
One characteristic for which we found dierences between constitutively transformed cells and recently induced cells was that the conventional Ras-cells exhibited elevated cyclin D1 levels in all growth phases, suggesting that during continued growth of transformed cells, the mechanism for downregulation of cyclin D1 at high cell densities becomes further impaired. However, since the cyclin D1 gene is not focus-forming, the elevated cyclin D1 expression seen at high cell densities is likely to cooperate with other Ras-induced changes for focus-growth. Although we have not yet identi®ed such key transformationassociated ras-induced molecular change(s) in our cells, the subtlety of the molecular eects we see with these cells that score as fully transformed, raises the possibility such change(s) may be distinct from conventionally identi®ed targets.
Our results contrast with those of other studies of ras transformation which have found that cells constitutively transformed by Ras can proliferate faster than untransformed control cells and that the transformants have reduced serum requirements for proliferation. It is not immediately obvious what accounts for the dierent properties we have observed. A lack of cell accumulation could arise if serum deprivation led to massive apoptosis in the Rasexpressing cells. We consider this highly unlikely, as we have not been able to ®nd any evidence for apoptosis. We do see an eect of expression of oncogenic Ras in the serum-starved cultures, since the cell loss seen in non-expressing cells is reversed. We do not know if the cell loss is apoptotic, nor do we know if the reversal is a speci®c reversal of the cell loss enabling the cells to respond to the low level of serum, Figure 4 Oncogenic Ras eects on cyclin D1 and pErk manifest themselves only under growth limiting conditions. Mib 125 cells from subcon¯uent cell cultures were plated in the absence or presence of tetracycline and growth followed by cell counts (a and b). Samples for extracts were taken from induced and uninduced (NI) cultures at the indicated times. Twenty mg of protein was loaded and the indicated proteins detected by Western blotting (c and d). The NIH3T3 sample is a low density sample of cells plated 24 h earlier in (c) the constitutively transformed Ras cells were harvested at low density after 24 h; in (d) high density cells were harvested. The blots were stripped after sequential detection of cyclin D1, Ras and pErk (in this order), and analysed for total Erk, which also functions as loading control whether the cell loss is still present but masked by a Ras-dependent induction of mitoses, or a mix of such mechanisms. However, in a number of studies, Ras transformation is associated with the synthesis of mitogenic ligands that can form autocrine loops which would be expected to reduce the requirement for mitogens present in serum. As predicted from the lack of growth in low serum, our Ras-transformed cells do not secrete autocrine factors able to support growth of NIH3T3 cells in low serum media (our unpublished results), perhaps because of our speci®c culture conditions. Regardless of the explanation, our data indicate that activated Ras can be transforming without altering the serum dependence of the cells.
Our observations suggest that the key eect of Ras on growth is to overcome contact inhibition. Cells induced for Ras at the density where they were about to quiesce resumed growth within 48 h. Conversely, Ras-expressing cells at a density above that of contact inhibition in non-induced cells, ceased their growth upon repression of Ras-synthesis. Hence, the eect of ras transformation is to overcome a block to serum induced mitogenesis present in the immortalized but non-transformed cells at the saturation density. We have analysed conditioned medium from parental and Ras-transformed cells for the ability to reverse the saturation density of the cells. No such activities were found: Ras-cells grew to high density in NIH3T3 conditioned medium, and uninduced cells reached their characteristic (low) saturation density when grown in Ras-conditioned medium (data not shown), suggesting that the eects are not due to soluble factors released into the medium. The reversibility of the Ras-eect suggests that Ras-induced gene products responsible for the loss of contact inhibition require continued Ras-activity. The nature and activities of these products is still unclear; however, as many oncogenes are characterized by the ability to induce foci in immortalized contact-inhibited murine ®broblasts, their targets are likely to be similar. The cell density attained by contact inhibited cells is dependent on the serum concentration and frequency of medium change, which suggests that high serum availability to some extent can overcome contact inhibition (Holley, 1975 ; and our unpublished observations). One possibility is that the oncogenes converge on components that allow transformed dense cells to respond to serum factors under conditions where well packed, organized, non-transformed cells cannot; another that the oncogenic signaling pathways interfere with the transmission of contact-induced growth inhibitory signals to the cell cycle machinery.
Since ras expression confers tumorigenicity to NIH-3T3 cells, but not a proliferative advantage at low cell density irrespective of the amount of growth factors in the medium, we conclude that loss of contact inhibition could be the tumor-relevant in vitro phenotype, at least in cells that do not contain autocrine loops. Our studies show that faster proliferation and serum independence achieved in cultured ®broblasts are characteristics conferred by events separable from the events induced by the Ras-oncogene. In vivo numerous genetic changes are required for a tumor to develop. Ras mutation is one such event which needs cooperation to lead to overt tumor-formation, as shown in carcinogenesis models where non-tumorigenic cells can harbor oncogenically mutated ras genes (Balmain et al., 1984; Sinn et al., 1987; Kumar et al., 1990) . The selective advantage conferred to cells in organisms by the ras oncogene might be tightly connected to its ability to favor cell division at high densities; this continued growth might promote increased rate of mutation of other genes whose eect leads to fully autonomous growth.
Materials and methods
Cell culture
Cells were grown in DMEM (Gibco ± BRL 52100) with 10% fetal calf serum (for Mib 123, 124 and 125, Gibco ± BRL 10108-165) or 10% newborn calf serum (for V1.6 and V1.9, Gibco ± BRL 26010-041). The tet-responsive cells and their controls were maintained in the presence of tetracycline (Sigma T3383) at 2 mg/ml. For serum starvation experiments, DMEM was supplemented with transferrin (0.5 mg/1, ICN 152334), NaSeO 3 (10 77 M, Sigma, S5261) and BSA-Linoleic Acid (0.5 mg BSA/ml, Sigma 8384), and cells were grown with 0.25% (V1.6 and V1.9) or 0.5% serum. Control experiments showed that if supplied in concentrations between 5 and 20%, 1 ml fetal calf serum could support cell accumulation of 3610 6 cells independently of whether it was administered at high concentration and low volume or the opposite, or whether it was supplied at the start of the experiments or in aliquots with media changes or later additions to media. The feeding schedule for individual experiments is noted in the Figure Plasmid constructions pSVlacOvHras (encoding v-H-ras under control of the LacI gene product, Repressor) was created in three steps. We generated a conditional reporter construct (pSVlacOb) based on the plasmid pCH110 (Hall et al., 1983) . pSVlacOb expresses b-galactosidase under transcriptional control of a modi®ed Simian Virus (SV40) early promoter/enhancer carrying a synthetic high anity lac operator (lacO) (Simons et al., 1984) , and the SV40 polyadenylation signal. This construct was used in the characterization of the induction kinetics in stably transfected NIH3T3 cell lines (Jacobsen and Willumsen, 1995) . pSVlacOb was made suitable for cloning of the v-H-ras gene under the same transcriptional control. A synthetic oligonucleotide designed to leave a HindIII site at its 3' end and encoding the ®rst four amino acids of the Ras protein was inserted into the HindIII site of the SV40 promoter. This regenerated a HindIII site for the subsequent cloning of the viral Harvey ras gene which has a HindIII restriction site at codon 5. A 3' cloning site was introduced by inserting a XhoI linker into the 3' end of the b-galactosidase gene, by deletion of an AvaI fragment. A 0.7 kb HindIII ± XhoI fragment from pBW1423 (Willumsen et al., 1991) carrying the rest of the v-H-ras coding frame was cloned into the HindIII and XhoI sites, generating pSVlacOvHras.
The v-H-ras gene was brought under control of the tet repressor by cloning it into the plasmid pTRE (Clontec, ®rst described as pUHD 10-3 (Gossen and Bujard, 1992) ), by excising a 2.2 kb BamHI fragment from pBW1423 carrying the open reading frame of v-H-ras and about 700 bases of upstream, untranslated sequences. This fragment essentially corresponds to the BamHl ± EcoRI fragment of the Harvey sarcoma virus clone H-1 nucleotides 3330-5540 (Ellis et al., 1980) , with a XhoI linker instead of the PstI site.
From this construct a 29 kd Ras-reactive (antibody 146-03E4 obtained from Quality Biotech) species is induced with the same kinetics as the 21 kd Ras protein. This protein likely represents an aberrant translation initiation event.
DNA transfection and clone selections
The cells expressing v-H-Ras under control of the Lac operator were obtained by cotransfecting pSVlacOvHras and pSV 2 neo into a NIH3T3 clone 7 derivative, RSVI60. RSVI60 expresses Lac-repressor from the plasmid pRSV-I (Hu and Davidson, 1987) and was generated by cotransfection (Willumsen, 1995) with the pSV 2 his plasmid (Hartman and Mulligan, 1988) and selection by growth in DMEM with 17 mM histidine supplemented with 500 mM histidinol (Sigma H6647). The pSVlacOvHras and pSV 2 neo transfected RSVI60 cells were selected in DMEM with histidinol and 500 mg/ml G418 (Gibco ± BRL 11811-031) in 96-well cell culture dishes and monitored during expansion for morphology and growth properties of single clones. A subset of clones was screened by focus formation assay for the ability to transform in the presence of inducer (1 mM isopropyl-b-Dthiogalactopyranoside (IPTG, Sigma I5502). Two clones 60V1.3 and 60V1.9 were selected that showed a high focusinducibility and, as importantly, a low focus forming activity when grown in absence of IPTG.
The cells conditionally expressing v-H-ras under the control of the tet operator were generated by transfection of N10 (provided by DR Lowy, an NIH3T3 clone 7 derivative, transfected with a plasmid encoding the tetrepressor pUHD 15-1 (Resnitzky et al., 1994) ), with the tetcontrolled v-H-ras-plasmid pBW 3774 (or empty vector). The day after transfection, the cells were distributed in twofold dilutions to 24-well plates; one plate per dilution. The cells received hygromycin (Boehringer Mannheim, cat no 843 555) the day after plating, and wells with¯at individual colonies picked 14 to 21 days later. Three transformed colonies were picked as well. For induction of tetracycline-repressed cells, the cells were trypsinized and resuspended in medium without tetracycline and plated, controls received tetracycline at 2 mg/ ml. Control experiments showed that no Ras-induction took place when trypsinized cells were incubated either at 48C or room temperature for up to 100 min without tetracycline.
Focus formation
Focus formation by the cell lines was made in co-cultivation assays where dilutions of inducible cells in NIH3T3 cells were plated and incubated for 10 ± 14 days for development of foci during induced or non-induced conditions. During the course of these experiments we found that the focus-forming eciency of Ras-cells in co-cultivation assays is aected by the density of non-transformed cells seeded in the assay. The speci®c conditions are noted for each assay shown. In some experiments, the plated cells were subject to hygromycin selection; this allowed colony formation of the inducible cells and thus quantitation of plating eciency.
Cell extracts
Cells were washed twice with PBS (room temperature) which was thoroughly aspirated; 200 ml 26SDS Laemli loading buer applied per 10 6 cells, the monolayer scraped o, and the extract transferred to eppendorf tubes in which the DNA was sheared by passage six times through a 27G needle. Alternatively, extracts were similarly prepared in LB (20 mM Tris pH 7.4, 100 mM NaCl, 5 mM MgCl 2 1% NP40, 0.5% Deoxycholate). The concentration of the extracts were estimated by blotting against Erk1 with extracts prepared in LB whose protein concentration was measured colorimetrically (Biorad cat no 500 0006) with BSA as a standard, with a correction for the twofold higher sensitivity of BSA in the assay.
Immunological procedures
Cell protein was run on 12.5% SDS gels and the separated protein blotted onto PDVF membranes (Amersham cat no RPN 2020F) by standard technique, after which the protein was ®xed in 0.25% glutardialdehyde in PBS with 0.05% Tween TM -20 (Merck, cat no 822184) (PBS-T), followed by four washes during 30 min. The membranes were developed with antibodies after blocking with 5% non-fat dry milk (Irma) in PBS-T at room temperature for 1 h. Primary antibody in the same buer was incubated with the blot for 12 ± 16 h at 48C. The blot was washed, incubated with HRPconjugated secondary antibody (Dako, Denmark) and developed with enhanced chemiluminescence (Amersham cat no RPN 2106 or 2132). The blots were stripped in 62.5 mM tris pH 6.7, 100 mM 2-mercapto ethanol, 2% (w/v SDS) for 30 min at 508C, extensively washed, blocked, and reprobed. Antibodies against cyclin D1 (sc-450), pErk (sc-7383) and Erk1 (sc-93) were from Santa Cruz, and against H-Ras (monoclonal 146-03E4) were puri®ed from ascites.
